Expertise in healthcare and medical device technologies, including microbiome solutions, lab-grown ingredients, diagnostic devices like in CGM, respiratory technologies, and more.
Banasmita is skilled in technology scouting, partner identification, competitor benchmarking, and market analysis, with a strong focus on business development and technology innovation to deliver tailored solutions and drive growth.
The European Commission has recently postponed the ban on TiO2 in medicinal products due to the lack of viable alternatives. This move highlights the overreliance on TiO2 and the need
In August 2025, the Microbiome Therapeutics Innovation Group (MTIG) petitioned the FDA to end the “IND loophole”. It’s a policy that allowed doctors to use unapproved stool-based (gut bacteria) treatments